| VAS Pain Scores | ||||
---|---|---|---|---|---|
 | Time scale | Treatments | |||
Study | Â | CS | HA | Placebo | |
 | Pain on walking 0-100 mm |  |  |  | |
Qvistgaard et al (101 patients) [41] | Baseline | 45 | 45 | 45 | |
 | Pain (14 days) | 33 | 37 | 46 | |
 | Pain (1 month) | 30 | 36 | 40 | |
 | Pain (3 months) | 36 | 36 | 39 | |
 | Pain at rest 0-100 mm |  |  |  | |
 | Baseline | 25 | 25 | 25 | |
 | Pain (14 days) | 22 | 23 | 29 | |
 | Pain (1 month) | 22 | 26 | 25 | |
 | Pain (3 months) | 23 | 27 | 28 | |
 | 0–20 Pain scale | CS | Placebo | ||
Kullenberg et al. (80 patients) [47] | Pain (Baseline) | 12.2 ± 2.2 | 12.0 ± 1.0 | ||
 | Pain (3 weeks) | 3.8 ± 2.6 | 12.4 ± 1.8 | ||
 | Pain (3 months) | 7.9 ± 3.9 | 12.4 ± 1.8 | ||
 |  | Group 0—CS | Group 1—CS + HA | Group 2—CS + HA | Group 3—CS + HA |
De Rezende et al. (82 patients) [50] | Pain (Baseline) | 63.8 (21.5) | 68.2 (21.8) | 55.8 (31.4) | 69.2 (20.9) |
 | Pain (1 month) | 35.5 (33.4) | 31.9 (22.0) | 28.4 (27.2) | 44.0 (34.3) |
 | Pain (3 months) | 44.3 (31.7) | 43.3 (21.9) | 40.1 (29.3) | 43.0 (29.7) |
 | Pain (6 months) | 46.2 (28.0) | 49.9 (30.0) | 37.6 (28.9) | 43.0 (31.4) |
 | Pain (12 months) | 40.3 (34.4) | 48.4 (27.0) | 40.8 (27.8) | 46.6 (27.7) |
 |  | CS | Ketorolac | ||
Jurgensmeier et al. (120 patients) [51] | Pain (Baseline) | 5.42 | 5.27 | ||
 | Pain (3 months) | 4.31 | 4.19 |